psychedelics investing Mydecine Innovations Group Announces Filing of a Provisional Patent for Mindleap's Mental Health Technology
psychedelics investing Mydecine Innovations Group Receives Conditional Approval to List on NEO Exchange
psychedelics investing Mydecine Innovations Group Sponsors Study on Neuron Level Response to Psilocybin at University of Maryland
psychedelics investing Mydecine Innovations Group Appoints Gordon Neal to Board of Directors and Dean Ditto as Chief Financial Officer
psychedelics investing Mydecine Innovations Group Sponsors First Lab-Based Study of Established Microdosers at Macquarie University in Australia
psychedelics investing Mydecine Innovations Group Engages ethica CRO as Contract Research Organization Partner for Phase 2A PTSD Clinical Trials
psychedelics investing Mydecine Innovations Group Engages the ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials
psychedelics investing Mydecine Innovations Group Partners with Microdose Psychedelic Insights to Present a Free, Live Webinar Series on The Renaissance of Psychedelics
psychedelics investing Mydecine Innovations Group to Make First Commercial Export of Legal Psilocybin Mushrooms
TomaGold Continues to Intersect Wide Zones of Zinc, Gold and Silver on Optioned Chibougamau Independent Claims
Angkor Resources' Subsidiary Receives Ministry of Environment Approval to Drill Four Sub-Basins on Block VIII, Cambodia
Copper Intelligence and CoTec Finalise Joint Venture Shareholder Agreement to Target Processing Historical Copper Tailings Opportunities in the Democratic Republic of Congo
Edgewater Wireless Reports First Quarter Fiscal 2027 Results and Advances PrismIQ Commercialization Roadmap
